{
"vaccines" : [{"id" : 0 ,
  "name" : " Inactivated Influenza (IIV) IM ",
  "indication" : "Recommended for all diabetic adults<b> because influenza can raise blood glucose to dangerously high levels </b> " ,
  "administration":"One <b>IIV</b> dose every year in the fall or winter" ,
  "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness with or without fever"
},

  {"id" : 1 ,
    "name" : " Pneumococcal conjugate (PCV13) IM ",
    "indication" : "All diabetic adults if some other risk factor is present: Age ≥65 years, Cerebrospinal fluid leak, Cochlear implant, Functional or anatomic asplenia, hemoglobinopathies, HIV infection, Chronic renal failure  and Nephrotic syndrome, Leukemia, Lymphoma, generalized malignancy, immunosuppression" ,
    "administration":"<b>Schedule for dual vaccination</b> - A single dose of PCV13 followed by a dose of PPSV23 ≥8 weeks later should be given for adults with diabetes mellitus who are ≥65 years or have any of the risk factors (mentioned before) and who have not previously received either PCV13 or PPSV23.<br> For patients who have previously received one or more doses of PPSV23, a  single dose of PCV13 should be given ≥1 year after the last PPSV23 dose was received.Revaccination with single dose of PPSV23 >5 year in immunocompromised and at 65 years old. " ,
    "contrain":"- Previous severe allergic reaction to this vaccine, including (for PCV13) to any diphtheria toxoid-containing vaccine, or to any of its components<br> - Moderate or severe acute illness"
  },

  {"id" : 2 ,
    "name" : " Pneumococcal polysaccharide (PPSV23) IM or SC ",
    "indication" : "All diabetic adults at any age" ,
    "administration":"<b>Schedule for dual vaccination</b> - A single dose of PCV13 followed by a dose of PPSV23 ≥8 weeks later should be given for adults with diabetes mellitus who are ≥65 years or have any of the risk factors (mentioned before) and who have not previously received either PCV13 or PPSV23.<br> For patients who have previously received one or more doses of PPSV23, a  single dose of PCV13 should be given ≥1 year after the last PPSV23 dose was received.Revaccination with single dose of PPSV23 >5 year in immunocompromised and at 65 years old." ,
    "contrain":"- Previous severe allergic reaction to this vaccine, including (for PCV13) to any diphtheria toxoid-containing vaccine, or to any of its components<br> - Moderate or severe acute illness"
  },


  {"id" : 3 ,
    "name" : "Hepatitis B (HepB) IM ",
    "indication" : "For all unvaccinated diabetics who are <60 yrs, and based on risk of exposure for older patients." ,
    "administration":"3-dose series at 0, 1 and 6 month intervals(the 2<small><sup>nd</small></sup> should be at least 4wks after the 1<small><sup>st</small></sup> and the 3<small><sup>rd</small></sup> should be at least 8wks after the 2<small><sup>nd</small></sup> and at least 16wks after the 1<small><sup>st</small></sup>)" ,
    "contrain":"- Previous severe allergic reaction<br> - Moderate or severe acute illness"
  },


  {"id" : 4 ,
    "name" : "Hepatitis A (HepA) IM ",
    "indication" : "All adults seeking protection from (HAV) infection and persons with other risk factors (e.g., traveling to countries with high or intermediate rates, have ch.<br> Liver dis or clotting factor disorders, illicit drug users, with recent exposure as post exposure prophylaxis)" ,
    "administration":"2 dose schedule with a minimum of 6 month interval" ,
    "contrain":"- Previous severe allergic reaction <br> - Moderate or severe acute illness"
  },

  {"id" : 5 ,
    "name" : "Tetanus, diphtheria, pertussis (Td/Tdap) IM ",
    "indication" : "All people who lack written documentation of a primary series consisting of at least 3 doses of tetanus- and diphtheria-toxoid-containing vaccine" ,
    "administration":"Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs" ,
    "contrain":"- Previous severe allergic reaction <br> - For Tdap only, history of encephalopathy not attributable to an identifiable cause, within 7d following DTP/DTaP, or Tdap"
  },


  {"id" : 6 ,
    "name" : "Zoster (shingles) ",
    "indication" : "-Shingrix (RZV) for adults ≥ 50 years. (IM) (Preferred)<br>-Zostavax (ZVL) for adults ≥ 60 years (SC).<br>-Whether Patients have a history of varicella or herpes zoster." ,
    "administration":"-Shingrix (RZV) 2 doses, 2-6 months apart.<br>-Zostavax (ZVL), 1 dose." ,
    "contrain":"-Shingrix (RZV) Patient with a known allergy to component of vaccine.<br>-Zostavax (ZVL) Previous severe allergic reaction primary cellular or acquired immunodeficiency.<br>-Pregnancy.<br>-Receipt of specific antivirals 24 hrs before vaccination.<br>-Moderate to severe acute illness."
  },


  {"id" : 7 ,
    "name" : "Measles, mumps, rubella (MMR) SC",
    "indication" : "Individuals at higher risk of either exposure or morbidity e.g., Healthcare personnel, college students, Military personnel, international travelers, Household and close contacts of immunocompromised persons, HIV-infected individuals who do not have current evidence of severe immunosuppression" ,
    "administration":"- Adults with no evidence of immunity should get 1 dose of MMR unless the adult is in a high risk group.<br> - Individuals at high risk should have two doses separated by at least one month or serologic evidence of immunity." ,
    "contrain":"- Previous severe allergic reaction<br> - Pregnancy or possibility of pregnancy within 4wks<br> - Immuno-compromising conditions<br> - Severe immunodeficiency<br> - History of thrombocytopenia or thrombocytopenic purpura"
  },

  {"id" : 8 ,
    "name" : "Varicella (chickenpox) SC ",
    "indication" : "All adults without evidence of immunity to varicella<small><sup>*</small></sup>" ,
    "administration":"- 2 doses <br> - Dose #2 is given 4—8 wks after dose #1.<br> - If dose #2 is delayed, do not repeat dose #1, just give dose #2." ,
    "contrain":"- Previous severe allergic reaction (e.g. anaphylaxis) <br> - Pregnancy<br> - Long-term immunosuppressive therapy or immunocompromised pts<br> - Receipt of specific antivirals <br> - Moderate or severe acute illness"
  }]
,"icon" : "sec5logo"
,"name" : "Diabetes"
,"ref" : "*Evidence of immunity to varicella in adults includes any of the following:<br>- Documentation of 2 doses of varicella vaccine at least 4 weeks apart<br>- History of varicella based on diagnosis or verification of varicella disease by a health care provider<br>- History of herpes zoster based on diagnosis or verification of herpes zoster disease by a health care provider <br>- Laboratory evidence of immunity or laboratory confirmation of disease.<br>1- Summary of Recommendations for Adult Immunization (Age 19 years and older). Centers for Disease Control and Prevention. 2016<br>2- VACCINATE ADULTS! from the Immunization Action Coalition.(19)1. March 2015. p. 1-22. Available at: http://www.immunize.org/va/va45.pdf<br>3- Centers for Disease Control and Prevention. Department of Health and Human Services.<br>http://www.cdc.gov/vaccines/hcp/patient-ed/adults/downloads/fs-diabetes-vaccines.pdf<br>4- National Foundation for Infectious Diseases. Available at: http://www.adultvaccination.org/professional-resources/pneumo/diabetes.pdf"
,"bg" : "sec5bg"
,"btnBg" : "sec5btnbg"
,"textColor" : "sec5color"
}
